Table 1.
Registered Clinical Trials of Gene Therapy for Retinal Diseases
Disease (Gene) |
ClinicalTrials.gov Identifier |
Vector Name |
Locations |
Key Publications |
LCA2 (RPE65) | NCT00481546 | rAAV2-CBSB-hRPE65 | University of Pennsylvania University of Florida Health Shands Hospital |
Bainbridge et al., 20086 Maguire et al., 20087 Cideciyan et al., 20088 Hauswirth et al., 20089 Simonelli et al., 201010 Cideciyan et al., 201311 |
NCT00516477 NCT00999609 NCT01208389 |
AAV2-hRPE65v2 AAV2-hRPE65v2 AAV2-hRPE65v2 |
Children's Hospital of Philadelphia, University of Iowa | ||
NCT00643747 | rAAV 2/2.hRPE65p.hRPE65 | Moorfields Eye Hospital | ||
NCT00749957 | rAAV2-CB-hRPE65 | Oregon Health and Science University University of Massachusetts-Worcester |
||
NCT00821340 | rAAV2-hRPE65 | Haddasah Medical Organization | ||
NCT01496040 | rAAV2/4.hRPE65 | Nantes Hospital | ||
RP38 (MERTK) | NCT01482195 | rAAV2-VMD2-hMERTK | King Khaled Eye Specialist Hospital | Deng et al., 201212 Conlon et al., 201313 |
Choroideremia (CHM) |
NCT01461213 NCT02077361 |
rAAV2.REP1 | Moorfields Eye Hospital University of Alberta |
Vasireddy et al., 201314 MacLaren et al., 201415 |
LHON (ND4) | NCT01267422 | rAAV2-ND4 | Tongji Hospital, Huazhong University of Science and Technology | Marella et al., 201016 |
Yu et al., 201217 | ||||
NCT02064569 | rAAV2/2-ND4 – GS010 | Centre Hospitalier Nationale d'Ophthalmologie des Quinze-Vingts | Chadderton et al., 201318 | |
NCT02161380 | scAAV2-P1ND4v2 | Bascom-Palmer Eye Institute | Lam et al., 201419 | |
Stargardt Disease (ABCA4) |
NCT01367444 NCT01736592 |
StarGen (EIAV-ABCA4) | Oregon Health and Science University Centre Hospitalier Nationale d'Ophthalmologie des Quinze-Vingts |
Kong et al., 200820 Binley et al., 201321 |
Usher1B (MYO7A) |
NCT01505062 NCT02065011 |
UshStat (EIAV-MYO7A) | Oregon Health and Science University Centre Hospitalier Nationale d'Ophthalmologie des Quinze-Vingts |
Hashimoto et al., 200722 Zallocchi et al., 201423 |